JusticeItaly Official institution
Italy authorizes parallel import of medicine Efexor
Italy's medicines regulator AIFA has published a notice authorizing the parallel import of Efexor, a human medicine, dated 3 November 2026. Parallel import means a medicine already approved in another country can be brought into Italy and sold under a separate Italian permit. The notice itself gives no further details in the excerpt provided.
This summary was generated by AI; the official source prevails.
What does it mean?
A medicine already sold in another country can now be brought into Italy and sold here under a separate Italian permit. This is a permit for Efexor, a medicine for people.
Who is affected?
People in Italy who use or buy Efexor, and the companies that import and sell it.